See also this year's filing and all EDGAR filings for this company.
PDF Report 0001677077_2024_Alzamend_Neuro_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001677077, Alzamend Neuro Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,835,782 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 79,843 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 2,870,122 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,469,990 |
| 9 | ResearchAndDevelopmentExpense | 10,635,006 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -17,062 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,915,625 |
| 1 | Liabilities | 2,870,122 |
| 2 | Expenses | 18,104,996 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,045,503 |
| 5 | NetIncome | -18,122,058 |
| 6 | ComprehensiveNetIncome | -18,122,058 |
| 7 | BaseVar | 13,453,902 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.61 |
| 9 | EconomicCapitalRatio | 0.817 |
Edgar->Model Mapping
Feature Distribution
Change over Time
